CHOC’s study published in the Pediatrics journal finds that though COVID-19 infections in newborns are rare, they may cause severe disease.
All Articles
New clinic and study site for patients with rare syndrome Fragile X opens in Thompson Autism and Neurodevelopmental Center
The Fragile X Clinic at CHOC will be devoted to the diagnosis, treatment, and study of the rare genetic condition of Fragile X syndrome.
CHOC conducts clinical trial for Glycogen Storage Disease type 1a
CHOC selected as West Coast site for gene therapy clinical trial for patients 8 years and older with Glycogen Storage Disease type 1a.
CHOC colorectal experts talk Hirschsprung disease, anorectal malformation
CHOC’s pediatric colorectal program makes a significant impact on children with treatments and tools for correcting colorectal issues.
Mental health specialists value being embedded in primary care clinics
New CHOC study integrating mental health into primary care seeks patients to receive cognitive therapy and/or medication.
NICU Bridge Program at CHOC — following up with high-risk infants
The NICU Bridge Clinic Program at CHOC offers follow-up care for high-risk infants, reducing the length of stays and hospital readmissions.
